Assembly Biosciences, Inc.
(NASDAQ : ASMB)

( )
ASMB After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corporation Plc Sponsored ADR
1.32%18.391.8%$132.24m
ICPTIntercept Pharmaceuticals, Inc.
4.05%90.5318.6%$94.99m
SAGESAGE Therapeutics, Inc.
0.89%166.988.8%$82.15m
JAZZJazz Pharmaceuticals Plc
3.03%129.782.3%$71.68m
GWPHGW Pharmaceuticals PLC Sponsored ADR
2.21%165.566.3%$60.71m
PRGOPerrigo Co. Plc
1.21%49.566.8%$54.61m
ZGNXZogenix, Inc.
0.48%37.399.9%$45.65m
UTHRUnited Therapeutics Corporation
5.53%104.3114.3%$44.47m
CTLTCatalent Inc
0.91%44.442.4%$39.76m
HZNPHorizon Pharma plc
2.98%25.266.7%$35.55m
PTLAPortola Pharmaceuticals, Inc.
2.76%35.407.6%$33.06m
ICLRICON Plc
3.89%135.054.1%$30.66m
ZYNEZynerba Pharmaceuticals Inc
4.21%9.908.3%$28.70m
MYOKMyoKardia, Inc.
2.06%49.072.4%$25.77m
MNKMallinckrodt Plc
3.15%18.3621.0%$25.24m

Company Profile

Assembly Biosciences, Inc. is a biotechnology company, which engages in the development of products for infectious diseases, such as chronic hepatitis B virus and illnesses associated with a dysbiotic microbiome. It focuses in two innovative platform programs: oral therapeutics for the treatment of hepatitis B virus, and the oral synthetic live biotherapeutics candidate. The company was founded by Uri Lopatin on October 7, 2005 and is headquartered in Carmel, IN.